Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 13/20 | 0.69 |
| ▸ | PDE4A | P27815 | 10/20 | 0.69 |
| ▸ | PDE4C | Q08493 | 10/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 10/20 | 0.69 |
| ▸ | CA1 | P00915 | 5/20 | 0.62 |
| ▸ | CA2 | P00918 | 5/20 | 0.62 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | PDE1A | P54750 | 1/20 | 0.48 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.48 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| An-2718 SCHEMBL5583381 | 1.00 | PDE4B (0.69) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL13183439 | 0.85 | CA1 (0.62) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL564786 | 0.82 | CA1 (0.65) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL2527365 | 0.82 | PDE4B (1.00) | PDE4BPDE4APDE4CPDE4DPDE3A | |
| Methylamine SCHEMBL14735124 | 0.78 | PDE4B (0.92) | PDE4BPDE4APDE4CPDE4DPDE3A | |
| SCHEMBL10268396 | 0.77 | CA1 (0.62) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL14473060 | 0.77 | CA1 (0.62) | PDE4BPDE4APDE4CPDE4DCA1 | |
| Tavaborole SCHEMBL500016 | 0.77 | CA1 (1.00) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL10220172 | 0.77 | CA1 (0.62) | PDE4BPDE4APDE4CPDE4DCA1 | |
| SCHEMBL15186178 | 0.77 | PDE4A (0.44) | PDE4BPDE4APDE4CPDE4DCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250099495-A1 | METHODS OF INHIBITING KLEBSIELLA PNEUMONIAE CARBAPENEMASE-2 | CITY UNIVERSITY OF HONG KONG (CN) | 2025-03-27 | — | — | US | claimed |
| US-12098159-B2 | Solid forms of substituted benzoxaborole and compositions thereof | 5METIS, INC. (US) | 2024-09-24 | — | — | US | claimed |
| US-20230159565-A1 | Solid Forms of Substituted Benzoxaborole and Compositions Thereof | 5METIS, INC. | 2023-05-25 | — | — | US | claimed |
| US-11560393-B2 | Solid forms of substituted benzoxaborole and compositions thereof | 5METIS, INC. (US) | 2023-01-24 | — | — | US | claimed |
| EP-4100413-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | AgroFresh Inc. (US) | 2022-12-14 | — | — | EP | claimed |
| CN-115348965-A | Antimicrobial compounds and compositions | 阿格洛法士公司 | 2022-11-15 | — | — | CN | claimed |
| US-11236115-B2 | Solid forms of substituted benzoxaborole and compositions thereof | 5METIS, INC. (US) | 2022-02-01 | — | — | US | claimed |
| WO-2021158595-A1 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | AGROFRESH INC. (US) | 2021-08-12 | — | — | WO | claimed |
| US-20210221827-A1 | SOLID FORMS OF SUBSTITUTED BENZOXABOROLE AND COMPOSITIONS THEREOF | Boragen, Inc. | 2021-07-22 | — | — | US | claimed |
| US-11066424-B2 | Solid forms of substituted benzoxaborole and compositions thereof | Boragen, Inc. (US) | 2021-07-20 | — | — | US | claimed |
| US-20160235070-A1 | FUNGICIDAL COMPOUNDS AND COMPOSITIONS | ALTER DOMUS US LLC | 2016-08-18 | — | — | US | claimed |
| WO-2016079536-A1 | ANTIFUNGAL AGENTS | F2G LIMITED (GB) | 2016-05-26 | — | — | WO | claimed |
| EP-2810946-B1 | 1,1'-[1,omega-alkyldiylbis(oxy)]bis[1,3-dihydro-2,1-benzoxaborole as volatile antimicrobial compounds | AGROFRESH INC (US) | 2016-04-13 | — | — | EP | claimed |
| WO-2015171186-A1 | COMPOUNDS AND NAIL POLISH | ANACOR PHARMACEUTICALS, INC. (US) | 2015-11-12 | — | — | WO | claimed |
| US-9138002-B2 | Compounds and compositions | AGROFRESH INC. (US) | 2015-09-22 | — | — | US | claimed |
| WO-2014197634-A2 | ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | DOW AGROSCIENCES LLC (US) | 2014-12-11 | — | — | WO | claimed |
| EP-2810946-A1 | 1,1'-[1,omega-alkyldiylbis(oxy)]bis[1,3-dihydro-2,1-benzoxaborole as volatile antimicrobial compounds | Dow AgroSciences LLC (US) | 2014-12-10 | — | — | EP | claimed |
| US-8889656-B2 | Boron-containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2014-11-18 | — | — | US | claimed |
| US-20140213551-A1 | COMPOUNDS AND COMPOSITIONS | DOW AGROSCIENCE LLC (US) | 2014-07-31 | — | — | US | claimed |
| US-8669207-B1 | Compounds and compositions | DOW AGROSCIENCES, LLC. (US) | 2014-03-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159565-A1 | Solid Forms of Substituted Benzoxaborole and Compositions Thereof | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-11066424-B2 | Solid forms of substituted benzoxaborole and compositions thereof | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-11560393-B2 | Solid forms of substituted benzoxaborole and compositions thereof | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-11236115-B2 | Solid forms of substituted benzoxaborole and compositions thereof | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-20140213551-A1 | COMPOUNDS AND COMPOSITIONS | OXA1L, CUL3, CUL2 | PDE4B 1316/4885PDE4A 2299/4885PDE4C 1842/4885 |
| US-20210221827-A1 | SOLID FORMS OF SUBSTITUTED BENZOXABOROLE AND COMPOSITIONS THEREOF | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-12098159-B2 | Solid forms of substituted benzoxaborole and compositions thereof | BRIX1, CYP2F1, XDH | PDE4B 3568/4885PDE4A 4313/4885PDE4C 4347/4885 |
| US-20160235070-A1 | FUNGICIDAL COMPOUNDS AND COMPOSITIONS | OXA1L, BROX, CUL3 | PDE4B 1090/4885PDE4A 1855/4885PDE4C 1436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.